Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.

P Ertzgaard, C Campo, A Calabrese - Journal of Rehabilitation …, 2017 - europepmc.org
Oral baclofen has long been a mainstay in the management of spasticity. This review looks
at the clinical evidence for the efficacy and safety of oral baclofen in patients with spasticity …

Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement …

D Dressler, R Bhidayasiri, S Bohlega, A Chahidi… - Journal of …, 2017 - Springer
Botulinum toxin (BT) therapy is an established treatment of spasticity due to stroke. For
multiple sclerosis (MS) spasticity this is not the case. IAB-Interdisciplinary Working Group for …

Localization of the center of the intramuscular nerve dense region of the medial femoral muscles and the significance for blocking spasticity

J Wang, Q Wang, D Zhu, Y Jiang, S Yang - Annals of Anatomy …, 2020 - Elsevier
Purpose To identify the body surface position and depth of the center of the intramuscular
nerves dense region (CINDR) of the medial femoral muscles. Methods Utilizing twelve …

[PDF][PDF] Шкала Тардье в диагностике спастичности

АП Коваленко, ВК Мисиков, ДА Искра… - … и психиатрии им …, 2019 - teachntouch.com
Резюме Диагностика, лечение и реабилитация пациентов со спастичностью остается
сложной задачей с еще не выработанными стандартными методическими подходами …

Спастичность: от патофизиологии к лечению

ДА Искра, АП Коваленко, МА Кошкарев… - Журнал неврологии и …, 2018 - elibrary.ru
В статье представлены современные взгляды на патофизиологию спастичности,
являющуюся частым инвалидизирующим следствием повреждения верхнего …

[PDF][PDF] Changes in body composition after spasticity treatment with intrathecal baclofen

O Skogberg, K Samuelsson, P Ertzgaard, R Levi - J Rehabil Med, 2017 - academia.edu
Objective: To assess changes in body composition, body weight and resting metabolic rate
in patients who received intrathecal baclofen therapy for spasticity. Design: Prospective …

Experiences from intrathecal baclofen treatment based on medical records and patient-and proxy-reported outcome: a multicentre study

S Gunnarsson, S Alehagen, D Lemming… - Disability and …, 2019 - Taylor & Francis
Purpose: To investigate patient satisfaction with intrathecal baclofen treatment,
complications from the treatment, and the impact of general expectations on treatment …

[HTML][HTML] PATIENTS'EXPECTATIONS BEFORE INITIATION OF INTRATHECAL BACLOFEN TREATMENT: A LONGITUDINAL STUDY WITH 1-YEAR FOLLOW-UP

S Gunnarsson, D Lemming, S Alehagen… - Journal of …, 2023 - ncbi.nlm.nih.gov
PATIENTS’ EXPECTATIONS BEFORE INITIATION OF INTRATHECAL BACLOFEN
TREATMENT: A LONGITUDINAL STUDY WITH 1-YEAR FOLLOW-UP - PMC Back to Top Skip to …

Spasticity: Diagnosis and Treatment

A Kovalenko, V Misikov, K Sinelnikov… - Neurostimulation …, 2020 - books.google.com
This chapter presents the technology of spasticity treatment—from diagnosis and treatment
to quality control of treatment and rehabilitation. The diagnosis is based on methods of …

Factors associated with the use of botulinum toxin injections for adult strabismus in the IRIS Registry

I Oke, T Elze, JW Miller, AC Lorch, DG Hunter… - Journal of American …, 2024 - Elsevier
This cross-sectional study used data from a large nationwide registry to describe the factors
associated with use of botulinum toxin injections for adults with strabismus in the United …